

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PARP ↓ ↑ | PARP1 ↓ ↑ | PARP2 ↓ ↑ | PARP3 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PJ34 HCl |
++
PARP, EC50: 20 nM |
99%+ | |||||||||||||||||
| Rucaparib phosphate |
++++
PARP, Ki: 1.4 nM |
99%+ | |||||||||||||||||
| 3-Aminobenzamide |
++
PARP, IC50: <50 nM |
98% | |||||||||||||||||
| AZD-2461 | ✔ | 99%+ | |||||||||||||||||
| BGP-15 | ✔ | 99%+ | |||||||||||||||||
| NU1025 |
+
PARP, IC50: 400 nM |
98% | |||||||||||||||||
| Benzamide |
+
PARP, IC50: 3.3 μM |
98% | |||||||||||||||||
| Picolinamide |
+
PARP, IC50: 95 μM |
98% | |||||||||||||||||
| AG14361 |
+++
PARP1, Ki: <5 nM |
98+% | |||||||||||||||||
| Iniparib | ✔ | 98% | |||||||||||||||||
| Talazoparib |
++++
PARP1, IC50: 0.57 nM |
99%+ | |||||||||||||||||
| NMS-P118 |
++
PARP1, Kd: 0.009 μM |
97% | |||||||||||||||||
| UPF 1069 |
+
PARP1, IC50: 8.0 μM |
++
PARP2, IC50: 0.3 μM |
98% | ||||||||||||||||
| A-966492 |
++++
PARP1, Ki: 1 nM PARP1, EC50: 1 nM |
+++
PARP2, Ki: 1.5 nM |
99%+ | ||||||||||||||||
| Veliparib |
++
PARP1, Ki: 5.2 nM |
+++
PARP2, Ki: 2.9 nM |
98% | ||||||||||||||||
| Niraparib tosylate |
+++
PARP1, IC50: 3.8 nM |
+++
PARP2, IC50: 2.1 nM |
99%+ | ||||||||||||||||
| Stenoparib |
++++
PARP1, IC50: 1 nM |
++++
PARP2, IC50: 1.2 nM |
98% | ||||||||||||||||
| Olaparib |
+++
PARP1, IC50: 5 nM |
++++
PARP2, IC50: 1 nM |
98% | ||||||||||||||||
| Niraparib |
+++
PARP1, IC50: 3.8 nM |
+++
PARP2, IC50: 2.1 nM |
98% | ||||||||||||||||
| ME0328 |
+
PARP1, IC50: 6.3 μM |
+
PARP3, IC50: 0.89 μM |
99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | ME0328 is recognized as a potent and selective ARTD3/PARP3 inhibitor, active within cellular environments. It demonstrates an ability to inhibit ARTD3's transferase activity, with an IC50 of 0.89±0.28 μM, as determined by in vitro histone H1 modification assays. In A549 human cells, both ME0328 and ME0355, at a concentration of 10 μM, prolong the presence of γH2AX foci, indicative of a delay in DNA double-strand break repair post γ-irradiation of 2 Gy. ME0328 has been characterized through in silico and in vitro analyses to be soluble, capable of cell penetration, and metabolically stable in human liver microsomes and rat hepatocytes[1]. |
| 作用机制 | ME0328 targets the nicotinamide binding site.[1] |
| Concentration | Treated Time | Description | References | |
| CHO cells | 3 μmol/L | 1 hour | ME0328 did not show statistically significant radiosensitization in CHO cells | Mol Cancer Ther. 2018 Oct;17(10):2206-2216. |
| A549 cells | 3 μM | ME0328 sensitized cells to pyridostatin | Nat Commun. 2017 Apr 27;8:15110. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.11mL 0.62mL 0.31mL |
15.56mL 3.11mL 1.56mL |
31.12mL 6.22mL 3.11mL |
|
| CAS号 | 1445251-22-8 |
| 分子式 | C19H19N3O2 |
| 分子量 | 321.37 |
| SMILES Code | O=C(N[C@H](C1=CC=CC=C1)C)CCC(N2)=NC3=C(C=CC=C3)C2=O |
| MDL No. | MFCD27991291 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | QIHBWVVVRYYYRO-ZDUSSCGKSA-N |
| Pubchem ID | 135566764 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 80 mg/mL(248.93 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1